7 found
Order:
  1.  8
    Amnestic MCI Patients’ Perspectives Toward Disclosure of Amyloid PET Results in a Research Context.Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rik Vandenberghe & Kris Dierickx - 2017 - Neuroethics 10 (2):281-297.
    BackgroundResearchers currently are not obligated to share individual research results with participants. This non-disclosure policy has been challenged on the basis of participants’ rights to be aware and in control of their personal medical information. Here, we determined how patients view disclosure of research PET results of brain amyloid and why they believe it is advantageous or disadvantageous to disclose.MethodAs a part of a larger diagnostic trial, we conducted semi-structured interviews with patients with amnestic Mild Cognitive Impairment. Participants had the (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  2.  12
    Stakeholders’ Views on Early Diagnosis for Alzheimer’s Disease, Clinical Trial Participation and Amyloid PET Disclosure: A Focus Group Study.Gwendolien Vanderschaeghe, Rik Vandenberghe & Kris Dierickx - 2019 - Journal of Bioethical Inquiry 16 (1):45-59.
    Detection of Alzheimer’s disease in an early stage is receiving increasing attention for a number of reasons, such as the failure of drug trials in more advanced disease stages, the demographic evolution, the financial impact of AD, and the approval of amyloid tracers for clinical use. Five focus group interviews with stakeholders were conducted.. The verbatim transcripts were analysed via the Nvivo 11 software. Most stakeholder groups wanted to know their own amyloid PET scan result. However, differences occurred between FGs: (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  3.  12
    Review of the Ethical Issues of a Biomarker-Based Diagnoses in the Early Stage of Alzheimer’s Disease. [REVIEW]Gwendolien Vanderschaeghe, Kris Dierickx & Rik Vandenberghe - 2018 - Journal of Bioethical Inquiry 15 (2):219-230.
    Background: Today, many healthcare or dementia organizations, clinicians, and companies emphasize the importance of detection of Alzheimer’s disease in an early phase. This idea has gained considerable momentum due to the development of biomarkers, the recent FDA and EMA approval of three amyloid tracers, and the failure of a number of recent therapeutic trials conducted in the early dementia phase. On the one hand, an early etiological diagnosis can lead to early and more efficacious intervention. On the other hand, it (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  3
    Electrocorticography of Spatial Shifting and Attentional Selection in Human Superior Parietal Cortex.Maarten Schrooten, Eshwar G. Ghumare, Laura Seynaeve, Tom Theys, Patrick Dupont, Wim Van Paesschen & Rik Vandenberghe - 2017 - Frontiers in Human Neuroscience 11.
  5.  20
    Dissociations Between Spatial-Attentional Processes Within Parietal Cortex: Insights From Hybrid Spatial Cueing and Change Detection Paradigms.Rik Vandenberghe & Céline R. Gillebert - 2013 - Frontiers in Human Neuroscience 7.
  6.  4
    Representation of Semantic Similarity in the Left Intraparietal Sulcus: Functional Magnetic Resonance Imaging Evidence.Veerle Neyens, Rose Bruffaerts, Antonietta G. Liuzzi, Ioannis Kalfas, Ronald Peeters, Emmanuel Keuleers, Rufin Vogels, Simon De Deyne, Gert Storms, Patrick Dupont & Rik Vandenberghe - 2017 - Frontiers in Human Neuroscience 11.
  7.  12
    Amnestic MCI Patients’ Perspectives on Volunteer Participation in a Research Context.Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rik Vandenberghe & Kris Dierickx - 2017 - Journal of Clinical Research and Bioethics 8 (3).
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark